Abbott Missed Expectations

Abbott (ABT) reported earnings of $1.26 per share on revenue of $11.14 billion for the second quarter ended June 2025. The consensus earnings estimate was $1.25 per share on revenue of $11.07 billion. The Earnings Whisper number was $1.27 per share. The company missed expectations by 0.79% while revenue grew 7.37% on a year-over-year basis.

The company said it expects third quarter earnings of $1.28 to $1.32 per share and now expects 2025 earnings of $5.10 to $5.20 per share. The company's previous guidance was 2025 earnings of $5.05 to $5.25 per share. The current consensus estimate is earnings of $1.34 per share for the quarter ending September 30, 2025 and earnings of $5.16 per share for the year ending December 31, 2025.

Abbott Laboratories discovers, develops, manufactures and sells health care products. Its products include branded generic pharmaceuticals manufactured internationally, marketed and sold outside the United States.